Nurix Therapeutics’ Hansen sells 1,452 shares
The October 30 sale was an issuer-plan tax-withholding transaction; the November 2 option-related sale was made under a previously adopted trading plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Nurix Therapeutics Chief Scientific Officer Gwenn Hansen reported an option exercise and stock sales on November 2, 2026, plus RSU vesting and a tax-withholding sale on October 30, 2026. She exercised options for 1,452 shares at $1.86 per share and sold 1,452 shares at $26.80 per share under a previously adopted Rule 10b5-1 plan. On October 30, 3,750, 2,859 and 3,573 RSUs vested into common shares; she sold 3,957 shares at a weighted average price of $26.2791 per share to cover tax withholding, as required by the issuer's equity plans.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
10 txns
Insider
Hansen Gwenn
Role
Chief Scientific Officer
Sold
5,409 shs ($143K)
Approx. gross sale proceeds
$143K
Approx. exercise cost
$3K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) F3, F9 | 1,452 | $0.00 | $0.00 |
| Exercise | Common Stock F3 | 1,452 | $1.86 | $3K |
| Sale | Common Stock F3 | 1,452 | $26.80 | $39K |
| Exercise | Restricted Stock Units F4, F5, F6 | 3,750 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units F4, F7, F6 | 2,859 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units F4, F8, F6 | 3,573 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,750 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,859 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,573 | $0.00 | $0.00 |
| Sale | Common Stock F1, F2 | 3,957 | $26.2791 | $104K |
Holdings After Transaction:
Restricted Stock Units — 60,380 contracts (Direct);
Employee Stock Option (right to buy) — 57,954 contracts (Direct);
Common Stock — 123,452 shares (Direct)
Footnotes (9)
- F1. The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- F2. Represents the weighted average sale price. The lowest price at which shares were sold was $26.135 and the highest price at which shares were sold was $26.42. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- F3. This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- F4. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- F5. The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2024, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting.
- F6. RSUs do not expire; they either vest or are canceled prior to the vest date.
- F7. The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2025, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting.
- F8. The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2026, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting.
- F9. The stock option vested as to 1/48 of the total shares monthly beginning June 10, 2019 until the option was fully vested on May 10, 2023.
Key Figures
Options exercised: 1,452 shares
Option exercise price: $1.86 per share
Option shares following exercise: 57,954 shares
+5 more
8 metrics
Options exercised
1,452 shares
November 2, 2026
Option exercise price
$1.86 per share
November 2, 2026
Option shares following exercise
57,954 shares
Reported after the November 2, 2026 transaction
Shares sold
1,452 shares
November 2, 2026
Sale price
$26.80 per share
November 2, 2026
Common shares issued upon RSU vesting
3,750; 2,859; and 3,573 shares
October 30, 2026
Tax-withholding sale
3,957 shares
October 30, 2026
Weighted average sale price
$26.2791 per share
October 30, 2026
Key Terms
Rule 10b5-1 trading plan, sell to cover, restricted stock units, weighted average sale price
4 terms
Rule 10b5-1 trading plan regulatory
"pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
sell to cover financial
"funded by a sell to cover transaction"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
restricted stock units financial
"restricted stock units ("RSUs")"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average sale price financial
"Represents the weighted average sale price"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were the vesting terms for Gwenn Hansen's NRIX RSUs?
The 3,750-share award's quarterly vesting began July 30, 2024; the 2,859-share award began July 30, 2025; and the 3,573-share award began July 30, 2026. Each award vests in 1/12 increments quarterly over three years, subject to Gwenn Hansen providing services to Nurix Therapeutics on each vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
